Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306

BACKGROUND: Tumor assessments after first-line therapy of RAS wild-type mCRC with cetuximab (cet) versus bevacizumab (bev) in combination with FOLFIRI were evaluated for factors influencing resectability, conversion to resectability, and survival after best response. METHODS: Conversion to resectabi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Surg Oncol
Hlavní autoři: Modest, Dominik Paul, Heinemann, Volker, Folprecht, Gunnar, Denecke, Timm, Pratschke, Johann, Lang, Hauke, Bemelmans, Marc, Becker, Thomas, Rentsch, Markus, Seehofer, Daniel, Bruns, Christiane J., Gebauer, Bernhard, Held, Swantje, Stahler, Arndt, Heinrich, Kathrin, von Einem, Jobst C., Stintzing, Sebastian, Neumann, Ulf P., Ricard, Ingrid
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2020
Témata:
Hepatobiliary Tumors
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7311511/
https://ncbi.nlm.nih.gov/pubmed/32172334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-020-08219-w
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky